ATM and cancer: Conversely, A-T patients with mild phenotype and adult-onset are characterized by low residual kinase activity (between 1% and 17% of functional ATM protein), due to missense or splice site mutations, and show mild neurodegeneration, but high cancer predisposition, even though delayed compared to classical A-T [28,29,30].